Showing results (151-160 of 231) with videos related to
Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 2011
Elevated bone turnover predicts for bone metastasis in postmenopausal breast cancer: results of NCIC CTG MA.14Allan Lipton, Judy-Anne W Chapman, Laurence Demers, et al.Leukemia|September 29, 2023
Chimeric kinase ALK induces expression of NAMPT and selectively depends on this metabolic enzyme to sustain its own oncogenic functionQian Zhang, Johnvesly Basappa, Hong Y Wang, et al.Cancer Research|March 5, 2009
Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcomaSofia Avnet, Laura Sciacca, Manuela Salerno, et al.Endocrine-Related Cancer|June 12, 2012
Stimulation of MC38 tumor growth by insulin analog X10 involves the serine synthesis pathwayHenning Hvid, Sarah-Maria Fendt, Marie-José Blouin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2011
Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06cFred Saad, Sebastien Hotte, Scott North, et al.Obesity (Silver Spring, Md.)|May 14, 2013
Serum leptin and adiponectin levels and risk of renal cell carcinomaLinda M Liao, Kendra Schwartz, Michael Pollak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2008
Phase I, pharmacokinetic and pharmacodynamic study of the anti-insulinlike growth factor type 1 Receptor monoclonal antibody CP-751,871 in patients with multiple myelomaMartha Q Lacy, Melissa Alsina, Rafael Fonseca, et al.Proceedings of the National Academy of Sciences of the United States of America|August 4, 2010
eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progressionLuc Furic, Liwei Rong, Ola Larsson, et al.European Urology|January 14, 2014
Metformin in chemotherapy-naive castration-resistant prostate cancer: a multicenter phase 2 trial (SAKK 08/09)Christian Rothermundt, Stefanie Hayoz, Arnoud J Templeton, et al.The Journal of Biological Chemistry|June 16, 2018
Insulin-like growth factor 1 receptor stabilizes the ETV6-NTRK3 chimeric oncoprotein by blocking its KPC1/Rnf123-mediated proteasomal degradationCristina E Tognon, Bo Rafn, Naniye Malli Cetinbas, et al.Pageof 24